Natus Medical (NTUS) 10-Q2016 Q1 Quarterly report

Filed: 4 May 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Argentina, back, borrowed, bulk, buy, cannibalization, classification, covered, enabling, expanded, fairly, FDA, February, hold, holdback, improve, Improvement, incorrect, Independent, installed, IOM, large, lessee, lifted, managerial, method, modified, Monarch, NeuroQuest, November, offer, prospective, prove, quality, retained, shift, shipping, simplify, stemming, uncertainty, understated

Removed: absolute, added, adjustment, allocation, announced, audit, began, capitalization, committee, complement, conceived, conclusion, consolidate, constituted, corrected, declined, deficiency, degree, Dollar, effectively, element, enhance, entering, ERP, error, ESPP, Euro, evaluate, expertise, fact, final, flat, group, immaterial, implement, inadequate, incremental, introduction, lack, loan, matter, met, misstatement, multiple, occurred, offsetting, operated, overhead, oversight, platform, precision, preliminary, proper, recent, redesigned, reduction, remedial, remediate, remediated, remediating, repayment, resource, restated, resulted, senior, Specifically, substantive, summary, taxed, Tender, Touch, valuation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

NTUS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO TITLE 18, UNITED STATES CODE, SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Natus Medical Incorporated (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James B. Hawkins, President and Chief Executive Officer of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




/s/ James B. Hawkins
Print Name: James B. Hawkins
Title: President and Chief Executive Officer
Date:	May 4, 2016

In connection with the Quarterly Report of Natus Medical Incorporated (the “Company”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jonathan Kennedy, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to Title 18, United States Code, Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




/s/ Jonathan A. Kennedy
Print Name: Jonathan A. Kennedy
Title: Senior Vice President and Chief Financial Officer
Date:	May 4, 2016

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.